Results 41 to 50 of about 83,002 (289)
Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson's Disease: The Systemic Synuclein Sampling Study (S4) [PDF]
BACKGROUND: α-synuclein is a lead Parkinson's disease (PD) biomarker. There are conflicting reports regarding accuracy of α-synuclein in different tissues and biofluids as a PD biomarker, and the within-subject anatomical distribution of α-synuclein ...
Adler, Charles H. +19 more
core +1 more source
Quantitative Characterization of α-Synuclein Aggregation in Living Cells through Automated Microfluidics Feedback Control [PDF]
Aggregation of α-synuclein and formation of inclusions are hallmarks of Parkinson's disease (PD). Aggregate formation is affected by cellular environment, but it has been studied almost exclusively in cell-free systems.
di Bernardo D. +3 more
core +1 more source
Additional file 5. Negative binomial mixed-effects model analysis of pser129 quantifications.
Rey, Nolwen +8 more
openaire +1 more source
Clinical Neuropathology image 5-2014: α-synuclein pathology in the ependyma in Parkinsonâs disease [PDF]
Not available.
openaire +2 more sources
Alpha-synuclein phosphorylated at serine 129 (S129) is highly elevated in Parkinson's disease patients where it mainly accumulates in the Lewy bodies. Several groups have studied the role of phosphorylation at the S129 in α-synuclein in a rat model for ...
Fabia Febbraro +6 more
doaj +1 more source
Parkinson's disease (PD) is characterized by the presence of α-synuclein aggregates known as Lewy bodies and Lewy neurites, whose formation is linked to disease development. The causal relation between α-synuclein aggregates and PD is not well understood.
Anichtchik, O. +12 more
core +1 more source
Additional file 2. List of antibodies, references and working concentrations.
Rey, Nolwen +8 more
openaire +1 more source
Synucleinopathies are neurodegenerative diseases in which α-synuclein protein accumulates in neurons and glia. In these diseases, α-synuclein forms dense intracellular aggregates that are disease hallmarks and actively contribute to tissue pathology ...
Andrew D. Sauerbeck +5 more
doaj +1 more source
Modelling α-synuclein processing in primary patient cells for pharmacological intervention
Aim: Parkinson’s disease (PD) is a complex, chronic neurodegenerative disorder with predominately sporadic etiology. Intricate genetic-environmental interactions lead to the hallmarks of the disease: degeneration of dopaminergic neurons and the ...
Jessica K. Smith +2 more
doaj +1 more source
Additional file 4. List of the abbreviations of brain regions used in the figures.
Rey, Nolwen +8 more
openaire +1 more source

